🇺🇸 FDA
Patent

US 6107457

Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth

expired A61KA61K38/00A61P

Quick answer

US patent 6107457 (Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth) held by The Board of Regents of the University of Texas System expires Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61P, A61P31/12